Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(12 sites)

United States

Woolfson Eye Institute, Atlanta, Georgia

Woolfson Eye Institute, Canton, Georgia

Woolfson Eye Institute, Cumming, Georgia

Woolfson Eye Institute, Douglasville, Georgia

Woolfson Eye Institute, Lawrenceville, Georgia

Woolfson Eye Institute, Marietta, Georgia

Woolfson Eye Institute, Snellville, Georgia

Woolfson Eye Institute, Asheville, North Carolina

Woolfson Eye Institute, Chattanooga, Tennessee

Woolfson Eye Institute, Johnson City, Tennessee

Woolfson Eye Institute, Knoxville, Tennessee